Evidence-Based Validation: Beyond the Classical RCT
In 2026, TCM clinical research has moved toward "Pragmatic Randomized Controlled Trials" (pRCTs). These studies are designed to respect the holistic and individualized nature of TCM while meeting international evidence standards.
Core Outcome Sets (COS): Researchers have developed standardized "outcome sets" that measure more than just physiological markers. They now include "Patient-Reported Outcomes" (PROs) such as vitality, tongue coating changes, and pulse quality to capture the full scope of TCM's effects.
Network Pharmacology: In 2026, this computational approach is the standard for understanding "multi-target" therapy. Instead of one drug for one receptor, AI models map how a 10-herb formula interacts with hundreds of protein pathways simultaneously to treat complex metabolic or immune disorders.